
TCMD · NASDAQ
Tactile Systems Technology, Inc.
$28.32 +3.50 (+14.10%)
Company overview
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers the Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; the Entre system, a portable pneumatic compression device used for the at-home treatment of venous disorders such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and the AffloVest, a portable high-frequency chest wall oscillation system for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NASDAQ
- Market cap
- $642M
- Employees
- 1,037
- Headquarters
- Minneapolis, MN
- Website
- tactilemedical.com
- CEO
- Sheri Louise Dodd
- Listed
- July 28, 2016
- P/E
- 31.74
- Dividend yield
- 0.00%
Company financials
- Revenue
- $344M
- Gross profit
- $260M
- Operating income
- $32.3M
- EBITDA
- $40.8M
- Net income
- $20.3M
- EPS
- $0.90
- Total assets
- $272M
- Total debt
- $15.2M
- Gross margin
- 75.68%
- Net margin
- 5.91%
- Earnings yield
- 3.15%
No geographic segmentation.
Showing FY 2025
News